FGEN 0.98 (-8.41%)
US31572Q8087BiotechnologyBiotechnology

FibroGen (FGEN) Stock Highlights

0.98 | -8.41%
2024-04-25 03:14:19
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGens revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the companys ability to advance product candidates.

Statistics

Range Today
0.93 1.1
Volume Today 2.17M
Range 1 Year
0.33 20.28
Volume 1 Year 729.83M
Range 3 Year
0.33 30.125
Volume 3 Year 1.22B
Range 10 Year
0.33 68.55
Volume 10 Year 2.23B

Highlights

Market Capitalization 113.59M (small)
Floating Shares 82.99M
Current Price 0.98
Price To Earnings -0.4
Price To Revenue 0.63
Earnings Per Share -2.92
Payout Ratio 0%

Performance

Latest -8.41%
1 Month -62.16%
3 Months +8.89%
6 Months +81.48%
1 Year -95.17%
3 Years -95.51%
5 Years -97.96%
10 Years -95.74%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.